Non-ST Segment Elevation Myocardial Infarction Secondary to Coronary Multi-Vessel Thrombosis in the Setting of
Aishwarya Sharma1, Abhishek Matta2,3, Danielle Matta4
1Infectious Disease, Sanford Health, Fargo, USA.
Insights
COVID-19 (Coronavirus disease 2019) can severely affect the heart, leading to various cardiovascular complications. Early detection using troponin and EKG, along with prompt treatment, is crucial for minimizing heart damage.
Area of Science:
- Cardiology
- Infectious Diseases
- Immunology
Background:
- COVID-19, caused by SARS-CoV-2, presents significant risks to cardiovascular health.
- Understanding the mechanisms linking viral infection to cardiac complications is critical.
Observation:
- SARS-CoV-2 infection induces excessive proinflammatory cytokines, causing systemic inflammation.
- This inflammation creates a procoagulant state, increasing the risk of cardiovascular events.
Findings:
- COVID-19 can manifest as congestive heart failure, arrhythmias, myocarditis, acute coronary syndrome (ACS), and nonischemic cardiomyopathy.
- Chest pain, dyspnea, and fatigue are key symptoms requiring attention for potential cardiac issues.
- Serial troponin levels and EKG changes are valuable prognostic markers for COVID-19 related cardiac injury.
Implications:
- Prompt identification and management of cardiovascular complications in COVID-19 patients are essential.
- Dissolving thrombi quickly can mitigate myocardial injury extent.
- Further research into cardiovascular impacts of viral infections is warranted.
Abstract:
Coronavirus disease 2019 (COVID-19) has been shown to impact the cardiovascular system by causing congestive heart failure, arrhythmias, myocarditis, acute coronary syndrome (ACS), or nonischemic cardiomyopathy. The infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) triggers the overproduction of proinflammatory cytokines, generating systemic inflammation and a procoagulant state that can lead to cardiovascular morbidity and mortality. Symptomatology may not be discrete with presentation of chest pain, dyspnea, and fatigue, so careful consideration should be applied to cardiovascular complications. Serial troponin dosage as well as EKG changes serve as viable prognosis markers. Prompt dissolution of the thrombi will minimize the extent of the myocardial injury.
More Related Videos
05:26Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
08:05Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Myocarditis III: Medical Management
Acute Coronary Syndrome III: Diagnostic Studies
Myocarditis II: Clinical Features and Diagnostic Tests
Acute Coronary Syndrome IV: Interprofessional Care
